Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Major Te Puke kiwifruit orchards marketed to foreign buyers

Major Te Puke kiwifruit orchards marketed to foreign buyers

By Paul McBeth

March 19 (BusinessDesk) - A block of three kiwifruit orchards in Te Puke is being marketed to foreign buyers, despite the new Labour-led government's plans to restrict overseas investment.

Bayleys Real Estate is marketing the Te Matai, Pacific Gold and Coachman orchards in Te Puke, spanning 98 canopy hectares in an international tender, closing on May 3, the realtor said in a statement. The three privately owned orchards are on track to produce 1.2 million-to-1.3 million trays of SunGold G3 and Hayward kiwifruit in roughly equal percentages, or about 0.9 percent of Zespri Group's total supply. That implies payments from Zespri of between $11.4 million and $12.3 million based on the 2017 payment of $9.76 per tray.

Kiwifruit orchard prices have soared since the government and industry response to the Psa bacteria incursion developed a resistant strain, and recent sales of land producing SunGold G3 varieties have gone for between $900,000 and $1 million per hectare, while green kiwifruit orchards able to be converted to gold have sold at $450,000-to-$500,000 per hectare. At an equal split, that implies a sale price of between $66 million and $74 million, not including 102 hectares of grazing land, two residential buildings, plus the option to buy $5.2 million of Zespri shares.

"The sheer scale of this Te Puke portfolio puts the trio of orchards among the biggest commercial kiwifruit operations in New Zealand and is certainly one of the largest that has ever been taken to market in one portfolio," Bayleys managing director Mike Bayley said. "The economy of scale delivered by purchasing this collection of orchards, which are all in close proximity to each other, allows for any new owner to maintain the corporate approach to crop management and production."

Australasia's biggest kiwifruit grower is NZX-listed Seeka, which produced 8.5 million trays in 2017 from its New Zealand orchards. The company last traded at $6.67, giving it a market value of $116.9 million.

The sale comes as policymakers hear submissions on amendments to the Overseas Investment Act bringing residential property and forestry cutting rights into the screening regime and after the government issued a directive to the Overseas Investment Office reducing the size of farms covered by OIO applications.

Bayley said buyers can bid for the entire portfolio or any of the individual properties.

(BusinessDesk)

ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Marine And Freshwater Reports: EDS Calls For Urgent Action On Marine Management

“There are some big issues to address. These include many marine species and habitats that are in serious trouble. Of the sample investigated, the report finds that 22% of marine mammals, 90% of seabirds and 80% of shorebirds are threatened with or actually at risk of extinction..." More>>

ALSO:

$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>

ALSO:

New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>

ALSO:

Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>

ALSO: